APVO - Aptevo Therapeutics GAAP EPS of $0.26 beats by $1.45
2023-05-11 09:24:36 ET
- Aptevo Therapeutics press release ( NASDAQ: APVO ): Q1 GAAP EPS of $0.26 beats by $1.45 .
- Aptevo had cash and cash equivalents as of March 31, 2023 totaling $25.3 million.
For further details see:
Aptevo Therapeutics GAAP EPS of $0.26 beats by $1.45